Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma

Proteomics

Volumn 8, Issue 10, 2008, Pages 2136-2149

  Lee, Nikki P Y ^a,b   Leung, Kar Wai ^a   Cheung, Nicole ^a   Lam, Brian Y ^a,c   Xu, Michelle Z ^a   Sham, Pak C ^b   Lau, George K ^a   Poon, Ronnie T P ^a,b   Fan, Sheung Tat ^a,b   Luk, John M ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Biomarkers; Hepatocellular carcinoma; Liver embryo; Oncofetal proteins; Proteomic profiling

Indexed keywords

MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; DEVELOPMENTAL STAGE; DISEASE COURSE; EMBRYO DEVELOPMENT; LINEAR REGRESSION ANALYSIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER DEVELOPMENT; LIVER DYSFUNCTION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS;

ANIMALS; ANIMALS, NEWBORN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; PROTEINS; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 44649124283     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700590     Document Type: Article

References (64)

1. Zhao, R., Duncan, S. A., Embryonic development of the liver. Hepatology 2005, 41, 956-967.
2. Zaret, K. S., Regulatory phases of early liver development: paradigms of organogenesis. Nat. Rev. Genet. 2002, 3, 499-512.
3. Lemaigre, F., Zaret, K. S., Liver development update: new embryo models, cell lineage control, and morphogenesis. Curr. Opin. Genet. Dev. 2004, 14, 582-590.
4. Costa, R. H., Kalinichenko, V. V., Holterman, A. X., Wang, X., Transcription factors in liver development, differentiation, and regeneration. Hepatology 2003, 38, 1331-1347.
5. Erlinger, S., Review article: new insights into the mechanisms of hepatic transport and bile secretion. J. Gastroenterol. Hepatol. 1996, 11, 575-579.
6. Thorgeirsson, S. S., Grisham, J. W., Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 2002, 31, 339-346.
7. Umeda, T., Hino, O., Molecular aspects of human hepatocarcinogenesis mediated by inflammation: from hypercarcinogenic state to normo- or hypocarcinogenic state. Oncology 2002, 62 Suppl. 1, 38-42.
8. Moss, S. F., Blaser, M. J., Mechanisms of disease: Inflammation and the origins of cancer. Nat. Clin. Pract. Oncol. 2005, 2, 90-97.
9. Sell, S., Cellular origin of hepatocellular carcinomas. Semin. Cell. Dev. Biol. 2002, 13, 419-424.
10. Wu, X. Z., Chen, D., Origin of hepatocellular carcinoma: Role of stem cells. J. Gastroenterol. Hepatol. 2006, 21, 1093-1098.
11. Llovet, J. M., Schwartz, M., Mazzaferro, V., Resection and liver transplantation for hepatocellular carcinoma. Semin. Liver. Dis. 2005, 25, 181-200.
12. Cormier, J. N., Thomas, K. T., Chari, R. S., Pinson, C. W., Management of hepatocellular carcinoma. J. Gastrointest. Surg. 2006, 10, 761-780.
13. Park, J. K., Lee, D. H., Bioartificial liver systems: current status and future perspective. J. Biosci. Bioeng. 2005, 99, 311-319.
14. Luk, J. M., Wang, P. P., Lee, C. K., Wang, J. H. et al., Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. J. Immunol. Methods 2005, 305, 39-47.
15. Teramoto, K., Asahina, K., Kumashiro, Y., Kakinuma, S. et al., Hepatocyte differentiation from embryonic stem cells and umbilical cord blood cells. J. Hepatobiliary Pancreat. Surg. 2005, 12, 196-202.
16. Epstein, R. J., Leung, T. W., Reversing hepatocellular carcinoma progression by using networked biological therapies. Clin. Cancer. Res. 2007, 13, 11-17.
17. Wang, X. Q., Luk, J. M., Leung, P. P., Wong, B. W. et al., Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma. Clin. Cancer. Res. 2005, 11, 483-489.
18. Lee, T. K., Man, K., Ho, J. W., Sun, C. K. et al., FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation. Carcinogenesis 2004, 25, 2397-2405.
19. Lee, T. K., Man, K., Ho, J. W., Wang, X. H. et al., FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin. Cancer Res. 2005, 11, 8458-8466.
20. Delaney IV, W. E., Isom, H. C., In vitro model systems for studying hepatitis B virus replication. In: Lai, C. L., Locarnini, S. (Eds.), Hepatitis B virus. International Medical Press, London 2002, pp. 55-79.
21. Lee, N. P., Tong, M. K., Leung, P. P., Chan, V. W. et al., Kidney claudin-19: localization in distal tubules and collecting ducts and dysregulation in polycystic renal disease. FEBS Lett. 2006, 580, 923-931.
22. Luk, J. M., Lam, C. T., Siu, A. F., Lam, B. Y. et al., Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 2006, 6, 1049-1057.
23. Luk, J. M., Su, Y. C., Lam, S. C., Lee, C. K. et al., Proteomic identification of Ku70/Ku80 autoantigen recognized by monoclonal antibody against hepatocellular carcinoma. Proteomics 2005, 5, 1980-1986.
24. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 1995, 57, 289-300.
25. Eisen, M. B., Spellman, P. T., Brown, P. O., Botstein, D., Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 1998, 95, 14863-14868.
26. Gillespie, J. R., Uversky, V. N., Structure and function of alpha-fetoprotein: a biophysical overview. Biochim. Biophys. Acta 2000, 1480, 41-56.
27. Mizejewski, G. J., Biological roles of alpha-fetoprotein during pregnancy and perinatal development. Exp. Biol. Med. (Maywood) 2004, 229, 439-463.
28. Song, H. H., Filmus, J., The role of glypicans in mammalian development. Biochim. Biophys. Acta 2002, 1573, 241-246.
29. Saftoiu, A., Ciurea, T., Georgescu, C., Banita, M. et al., Immunohistochemical assessment of proliferating cell nuclear antigen in primary hepatocellular carcinoma and dysplastic nodules. J. Cell. Mol. Med. 2003, 7, 436-446.
30. Osada, S., Saji, S., Kuno, T., Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma. J. Surg. Oncol. 2004, 85, 48-54.
31. Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N. et al., Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 2003, 3, 2487-2493.
32. Grandchamp, B., Phung, N., Nordmann, Y., The mitochondrial localization of coproporphyrinogen III oxidase. Biochem. J. 1978, 176, 97-102.
33. Yoshinaga, T., Purification and properties of coproporphyrinogen III oxidase from bovine liver. Methods Enzymol. 1997, 281, 355-367.
34. Blanc, J. F., Lalanne, C., Plomion, C., Schmitter, J. M. et al., Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005, 5, 3778-3789.
35. Shuda, M., Kondoh, N., Tanaka, K., Ryo, A. et al., Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res. 2000, 20, 2489-2494.
36. Hippo, Y., Watanabe, K., Watanabe, A., Midorikawa, Y. et al., Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res. 2004, 64, 2418-2423.
37. Wang, X. Q., Luk, J. M., Garcia-Barcelo, M., Miao, X. et al., Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma. Clin. Cancer Res. 2006, 12, 5248-5252.
38. Wong, B. W., Luk, J. M., Ng, I. O., Hu, M. Y. et al., Identification of liver-intestine cadherin in hepatocellular carcinoma - a potential disease marker. Biochem. Biophys. Res. Commun. 2003, 311, 618-624.
39. Zaret, K. S., Hepatocyte differentiation: from the endoderm and beyond. Curr. Opin. Genet. Dev. 2001, 11, 568-574.
40. Yu, Y., Zhang, C., Zhou, G., Wu, S. et al., Gene expression profiling in human fetal liver and identification of tissue-and developmental-stage-specific genes through compiled expression profiles and efficient cloning of full-length cDNAs. Genome Res. 2001, 11, 1392-1403.
41. Ying, W., Jiang, Y., Guo, L., Hao, Y. et al., A dataset of human fetal liver proteome identified by subcellular fractionation and multiple protein separation and identification technology. Mol. Cell. Proteomics 2006, 5, 1703-1707.
42. Yun, J. P., Miao, J., Chen, G. G., Tian, Q. H. et al., Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters. Br. J. Cancer 2007, 96, 477-484.
43. Yokoyama, Y., Kuramitsu, Y., Takashima, M., Iizuka, N. et al., Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 2004, 4, 2111-2116.
44. Varotti, G., Ramacciato, G., Ercolani, G., Grazi, G. L. et al., Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. Eur. J. Surg. Oncol. 2005, 31, 760-767.
45. Budhu, A. S., Zipser, B., Forgues, M., Ye, Q. H. et al., The molecular signature of metastases of human hepatocellular carcinoma. Oncology 2005, 69 Suppl. 1, 23-27.
46. Talwalkar, J. A., Gores, G. J., Diagnosis and staging of hepatocellular carcinoma. Gastroenterology 2004, 127, S126-S132.
47. Sun, W., Xing, B., Sun, Y., Du, X. et al., Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol. Cell. Proteomics 2007, 6, 1798-1808.
48. Hendrix, M. J., Seftor, E. A., Seftor, R. E., Kasemeier-Kulesa, J. et al., Reprogramming metastatic tumour cells with embryonic microenvironments. Nat. Rev. Cancer 2007, 7, 246-255.
49. Duncan, S. A., Mechanisms controlling early development of the liver. Mech. Dev. 2003, 120, 19-33.
50. Luk, J. M., Wong, K. F., Monoclonal antibodies as targeting and therapeutic agents: prospects for liver transplantation, hepatitis and hepatocellular carcinoma. Clin. Exp. Pharmacol. Physiol. 2006, 33, 482-488.
51. Mohr, L., Yeung, A., Aloman, C., Wittrup, D. et al., Antibody-directed therapy for human hepatocellular carcinoma. Gastroenterology 2004, 127, S225-S231.
52. Llovet, J. M., Updated treatment approach to hepatocellular carcinoma. J. Gastroenterol. 2005, 40, 225-235.
53. Bruix, J., Hessheimer, A. J., Forner, A., Boix, L. et al., New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene 2006, 25, 3848-3856.
54. Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P. et al., Hepatic fibrosis: molecular mechanisms and drug targets. Annu. Rev. Pharmacol. Toxicol. 2005, 45, 605-628.
55. Fausto, N., Tweaking liver progenitor cells. Nat. Med. 2005, 11, 1053-1054.
56. Zender, L., Spector, M. S., Xue, W., Flemming, P. et al., Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006, 125, 1253-1267.
57. Li, C., Tan, Y. X., Zhou, H., Ding, S. J. et al., Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers. Proteomics 2005, 5, 1125-1139.
58. Tauber, Z., Lichnovsky, V., Kolar, Z., Proliferating cell nuclear antigen in tissues and organs of human embryos. Acta Univ. Palacki Olomuc. Fac. Med. 1995, 139, 29-32.
59. Liang, C. R., Leow, C. K., Neo, J. C., Tan, G. S. et al., Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2005, 5, 2258-2271.
60. Qanungo, S., Mukherjea, M., Ontogenic profile of some antioxidants and lipid peroxidation in human placental and fetal tissues. Mol. Cell. Biochem. 2000, 215, 11-19.
61. Mera, N., Ohmori, S., Itahashi, K., Kiuchi, M. et al., Immunochemical evidence for the occurrence of Mu class glutathione S-transferase in human fetal livers. J. Biochem. 1994, 116, 315-320.
62. Varela-Echavarria, A., Montes de Oca-Luna, R., Barrera-Saldana, H. A., Uricase protein sequences: conserved during vertebrate evolution but absent in humans. FASEB J. 1988, 2, 3092-3096.
63. Karsai, T., Elodi, P., Urea cycle enzymes in human liver: ontogenesis and interaction with the synthesis of pyrimidines and polyamines. Mol. Cell. Biochem. 1982, 43, 105-110.
64. Suzuki, T., Ono, T., Immunohistochemical studies on the distribution and frequency of fatty-acid-binding protein positive cells in human fetal, newborn and adult liver tissues. J. Pathol. 1987, 153, 385-394.